Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Medis Pharma Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

Cancellation by sponsor (1484)
Cancellation or suspension (26)
ARTG (21)
Listed medicine compliance report (5)
Prescription medicine registration (2)

Date

2026 (27)
2025 (58)
2024 (1215)
2023 (3)
2022 (29)
2021 (106)
2020 (31)
2019 (6)
2018 (3)
2017 (41)
2015 (2)
2014 (3)
2013 (1)
2012 (6)
2011 (6)
2009 (1)

Search

Sponsor content

1538 result(s) found, displaying 1321 to 1330

FOSETIC 20/12.5 fosinopril sodium 20 mg and hydrochlorothiazide 12.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2022

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ONDANSETRON MEDIS ondansetron (as hydrochloride dihydrate) 8mg/4mL injection solution ampoule Cancelled under Section 30(1)(c) of the Act

29 June 2022

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
VANCOMYCIN AN vancomycin 1000 mg (as hydrochloride) powder for injection vial Cancelled under Section 30(1)(c) of the Act

29 June 2022

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
VANCOMYCIN AN vancomycin 500mg (as hydrochloride) powder for injection vial Cancelled under Section 30(1)(c) of the Act

29 June 2022

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
ZEDD 500 azithromycin 500mg (as monohydrate) tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2022

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
MOMASONE mometasone furoate 0.1% cream tube Cancelled under Section 30(1)(c) of the Act

29 June 2022

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
VEDILOL 12.5 carvedilol 12.5 mg tablet blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2022

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
IQUIT Regular Strength nicotine 2mg mint coated chewing gum blister pack Cancelled under Section 30(1)(c) of the Act

29 June 2022

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
QUITX nicotine 2mg freshmint coated chewing gum blister pack (new formulation) Cancelled under Section 30(1)(c) of the Act

29 June 2022

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd
QUITX nicotine 4mg freshmint coated chewing gum blister pack (new formulation) Cancelled under Section 30(1)(c) of the Act

29 June 2022

Cancellation by sponsor

Requested by Medis Pharma Pty Ltd

Pages

First page
Previous page
…
Page 129
Page 130
Page 131
Page 132
Current page 133
Page 134
Page 135
Page 136
Page 137
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.